Skip to main content
logo
Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.000
-0.050 (-1.23%)
Sep 14, 2026, 9:30 AM EDT - Market open

Alterity Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
3.613.615.444.023.925.12
Revenue Growth
-45.60%-33.63%35.32%2.63%-23.56%18.06%
Gross Profit
3.353.355.313.83.634.76
Operating Income
-25.09-25.09-14.66-19.61-14.64-15.5
Net Income
-23.4-23.4-12.15-19.12-13.81-12.85
Earnings Per Share
-0.11-0.11-0.09-0.26-0.28-0.27
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
37.3237.3240.6612.6415.7734.81
Total Debt
0.190.190.160.160.210.12
Net Cash (Debt)
37.1237.1240.512.4815.5634.69
Net Cash Growth
-24.39%-8.34%224.55%-19.81%-55.13%23.67%
Net Cash Per Share
0.180.180.320.170.320.72

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-22.52-22.52-11.45-12.61-20.04-12.34
Capital Expenditures
----0.01-0.01-0.09
Free Cash Flow
-22.52-22.52-11.45-12.61-20.04-12.43
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
92.72%92.72%97.66%94.67%92.72%92.88%
Operating Margin
-695.13%-695.13%-269.57%-487.82%-373.72%-302.56%
Pretax Margin
-645.08%-645.08%-222.10%-474.65%-349.87%-249.38%
Profit Margin
-648.22%-648.22%-223.35%-475.79%-352.54%-250.75%
FCF Margin
-623.91%-623.91%-210.54%-313.78%-511.78%-242.54%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
28.5234.6516.785.224.366.11